Barbara K. Finck - 16 Mar 2022 Form 3 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
Director
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Issuer symbol
FBRX
Transactions as of
16 Mar 2022
Net transactions value
$0
Form type
3
Filing time
18 Mar 2022, 17:19:34 UTC
Next filing
20 May 2022
SEC
View on sec.gov

No securities are beneficially owned.